| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/11/2009 | US20090148495 Optimum Density Fibrous Matrix |
| 06/11/2009 | US20090148486 Compositions and methods for treating pulp inflammations caused by infection or trauma |
| 06/11/2009 | US20090148471 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 06/11/2009 | US20090148452 Composition for treating cancer adapted for intra-tumoral administration and uses thereof |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148425 Therapeutic method for blood coagulation disorder |
| 06/11/2009 | US20090148424 Reversibly immortalized mammalian liver cells and use thereof |
| 06/11/2009 | US20090148423 Endothelial progenitor cells and methods of use thereof |
| 06/11/2009 | US20090148422 Methods of proliferating stem cells |
| 06/11/2009 | US20090148421 Compositions comprising vascular and myocyte progenitor cells and methods of their use |
| 06/11/2009 | US20090148420 Stem cells |
| 06/11/2009 | US20090148419 Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| 06/11/2009 | US20090148418 Skeletal Site-Specific Characterization of Orofacial and Illiac Crest Human Bone Marrow Stromal Cells in Same Individuals |
| 06/11/2009 | US20090148417 Carbon nanotubes serving as stem cell scaffold |
| 06/11/2009 | US20090148416 Angiogenically induced transplants and methods for their use and manufacture |
| 06/11/2009 | US20090148415 Treatment for Chronic Myocardial Infarct |
| 06/11/2009 | US20090148414 Novel Composition to Improve Gut Health and Animal Performance and Methods of Making the Same |
| 06/11/2009 | US20090148412 lowering plasma cholesterol level in a subject by administering a preparation comprising an isolated membrane fraction separated from cytoplasmic material, the membrane fraction made from bacteria of Rhodospirillum spp. and/or Phaeospirillum spp |
| 06/11/2009 | US20090148411 Viral vector-based gene therapy methods and compositions |
| 06/11/2009 | US20090148410 Improving the health of a companion animal; reducing pathogenic bacteria in feces, reducing stress, autoimmune disease, aging, kidney stones |
| 06/11/2009 | US20090148409 For improving the health of a companion animal; reducing pathogenic bacteria in feces, reducing stress, autoimmune disease, aging, kidney stones |
| 06/11/2009 | US20090148408 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 06/11/2009 | US20090148405 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf) receptor ligands |
| 06/11/2009 | US20090148404 Compositions and methods for eliminating undesired subpopulations of t cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
| 06/11/2009 | CA2743698A1 Compositions comprising vascular and myocyte progenitor cells and methods of their use |
| 06/11/2009 | CA2743697A1 Methods of isolating non-senescent cardiac stem cells and uses thereof |
| 06/11/2009 | CA2743682A1 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells |
| 06/11/2009 | CA2708050A1 Method for expanding hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | CA2707656A1 Probiotic bacteria and regulation of fat storage |
| 06/11/2009 | CA2707352A1 Activity of recombinant equine follicle stimulating hormone |
| 06/11/2009 | CA2706458A1 Process for reducing effects of graft versus host disease using ex vivo expanded cd4+cd25+ regulatory t cells |
| 06/10/2009 | EP2067862A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067482A1 Agent for preventing development of reflex sympathetic dystrophy after stroke |
| 06/10/2009 | EP2067478A1 Agent for prevention or treatment of blood glucose level elevation |
| 06/10/2009 | EP2066332A1 Flu vaccine admixture of mannan and flu antigen |
| 06/10/2009 | EP1685254B1 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 06/10/2009 | EP1383869B1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 06/10/2009 | EP1051116B8 Embolization device |
| 06/10/2009 | CN101454013A Compositions and methods for producing fermentation products and residuals |
| 06/10/2009 | CN101450083A Use of clostridium butyricum in preparing composition for treating newborn feeding intolerance |
| 06/10/2009 | CN101450082A Vagina disease treatment medicine using biologic live bacteria |
| 06/10/2009 | CN101450081A External traditional Chinese medicine for treating burn and scald |
| 06/10/2009 | CN101450080A Traditional Chinese medicine composition for treating AIDS |
| 06/10/2009 | CN101450079A Traditional Chinese medicine composition for treating disease in mouth |
| 06/10/2009 | CN101450078A Cervus elaphus Linnaeus polyamine extraction method |
| 06/10/2009 | CN100497639C Means and methods for the production of adenovirus vectors |
| 06/10/2009 | CN100497602C Stem cell, and its preparing process and usage |
| 06/10/2009 | CN100497598C Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/10/2009 | CN100496514C Treatment of surfaces populated by bacteria |
| 06/10/2009 | CN100496513C Bone density-increasing and senility-postponing capsule formulation |
| 06/10/2009 | CN100496512C Pearl suspension |
| 06/10/2009 | CN100496511C Preparation method of Bingling ointment for curing burn and scald |
| 06/10/2009 | CN100496247C Fluid composition for increased total water intake |
| 06/09/2009 | US7544655 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 06/09/2009 | US7544511 Generating stable human aggregates in vitro; prepare culture neuronal stem cells, transform cell, incubate with mitogen, recover stable aggregates |
| 06/09/2009 | US7544510 Stem cells of the islets of Langerhans and their use in treating diabetes mellitus |
| 06/09/2009 | US7544509 Method for preparing stem cell preparations |
| 06/09/2009 | US7544486 transfecting a mammalian cell with nucleic acid construct to express bone growth factor; implants; inducing osteogenic differentiation, osteoblastic mineralization and/or bone formation in clinical applications; lower doses of each growth factor hence cheaper; for treating bone disorders |
| 06/09/2009 | US7544474 Monitoring sample for preferential particles; obtain sample, incubate on test column, wash column, incubate with probes, wash column, detect signals; using chemiluminescence labels acridinium dye; diagnosing diseases by detect nucleic acid has been used for diseases associated with abnormal gene products |
| 06/09/2009 | US7544374 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/09/2009 | US7544363 Exhibit probiotic activity in aerobic conditions; does not contribute to the production of future generation of antibiotic resistant pathogens |
| 06/09/2009 | US7544355 Methods and compositions for allogeneic transplantation |
| 06/09/2009 | CA2391737C Method for drying bacteria |
| 06/09/2009 | CA2388939C Therapeutic treatments for blood cell deficiencies |
| 06/09/2009 | CA2297984C Ratite extracts as therapeutic agents |
| 06/09/2009 | CA2276183C Pharmaceutical preparations of glutathione and methods of administration thereof |
| 06/09/2009 | CA2265521C Anti-bacterial composition for treating acne |
| 06/09/2009 | CA2155017C Vpr function and activity |
| 06/04/2009 | WO2009070687A1 Solvent systems for pour-on formulations for combating parasites |
| 06/04/2009 | WO2009069991A2 Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua or adipose |
| 06/04/2009 | WO2009069800A1 Novel aminoglycoside antibiotic, method for producing the same, and pharmaceutical use of the same |
| 06/04/2009 | WO2009069704A1 Lactic acid bacterium having effect of lowering blood uric acid level |
| 06/04/2009 | WO2009068997A1 Use of a l. casei strain, for the preparation of a composition for inhibiting mast cell activation |
| 06/04/2009 | WO2009068870A1 Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 06/04/2009 | WO2009068753A1 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 06/04/2009 | WO2009068615A1 Ex vivo method for producing a preparation containing cd4+ t cells specific for ebv structural antigens |
| 06/04/2009 | WO2009068600A1 Compositions for reducing dental erosion |
| 06/04/2009 | WO2009068474A1 Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect |
| 06/04/2009 | WO2009067808A1 Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors |
| 06/04/2009 | WO2009037439A3 Methods of switching the phenotype of t cells by transgenic lineage factor foxp3 |
| 06/04/2009 | WO2009028870A4 Composition for the diagnosis, prevention or treatment of diseases related to cells expressing il-8 or gro-alpha, comprising ucb-mscs |
| 06/04/2009 | WO2009027753A4 Composition and method inhibiting inflammation |
| 06/04/2009 | WO2008134814A4 A method for treating inflammation and controlled-release material capable of providing same |
| 06/04/2009 | WO2008013630A3 Calcium aluminosilicate pharmaceutical |
| 06/04/2009 | US20090143714 Regulation of Mammalian Keratinous Tissue Using Skin and/or Hair Care Actives |
| 06/04/2009 | US20090143296 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 06/04/2009 | US20090143278 Process for preparing bioactive protein-enriched whey products |
| 06/04/2009 | US20090143277 Nutritional composition for controlling blood sugar level |
| 06/04/2009 | US20090142841 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 06/04/2009 | US20090142834 Multipotent stem cells from peripheral tissues and uses thereof |
| 06/04/2009 | US20090142831 Placental stem cells |
| 06/04/2009 | US20090142431 Algal and algal extract dietary supplement composition |
| 06/04/2009 | US20090142430 Methods for Preventing or Treating Complications of Airway Control Devices |
| 06/04/2009 | US20090142429 Silicibacter sp. strain useful for genetic transformation of marine algae and production of antibiotic agents |
| 06/04/2009 | US20090142409 Extracellular Matrix Compositions for Tissue Regeneration |
| 06/04/2009 | US20090142403 Organ regeneration device |
| 06/04/2009 | US20090142375 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses madiated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 06/04/2009 | US20090142331 Method for the Production of Bio-Active Substances from the Novel Actinomycete TAXA MAR3A, MAR3B And MAR4 Belonging to the Family Treptomycetaceae |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |